Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years

Randomized trials demonstrated the superiority of chemoimmunotherapy over chemotherapy in the frontline treatment of CLL. Based on favorable experience with the addition of mitoxantrone (M) to fludarabine (F) plus cyclophosphamide (C), we designed a pilot study testing the combination of FCM plus ri...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leuk Res
Autors principals: Faderl, Stefan, Wierda, William, O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan, Keating, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845644/
https://ncbi.nlm.nih.gov/pubmed/19646755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2009.07.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars